Skip to main content
. 2019 Sep 19;6(1):e000349. doi: 10.1136/lupus-2019-000349

Figure 2.

Figure 2

Initiation of prednisone and HCQ by two-tiered test results in MAP/CB-CAPs testing arm. Fisher’s exact p values comparing the three groups are are provided. Prednisone and HCQ were initiated in 22% and 33% patients testing positive for MAP/CB-CAPs (positive tier 1 or positive tier 2), respectively. CB-CAPs, cell-bound complement activation products; HCQ, hydroxychloroquine.